UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
August 5, 2008
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED)
BLUE NILE, INC.
(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
|
|
|
|
|
DELAWARE
|
|
000-50763
|
|
91-1963165 |
|
|
|
|
|
(STATE OR OTHER JURISDICTION
|
|
(COMMISSION FILE
|
|
(I.R.S. EMPLOYER |
OF INCORPORATION)
|
|
NUMBER)
|
|
IDENTIFICATION NO.) |
705 FIFTH AVENUE SOUTH, SUITE 900, SEATTLE, WASHINGTON, 98104
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES, INCLUDING ZIP CODE)
(206) 336-6700
REGISTRANTS TELEPHONE NUMBER, INCLUDING AREA CODE
N/A
(FORMER NAME OR FORMER ADDRESS IF CHANGED SINCE LAST REPORT)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
o |
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
o |
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
o |
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
o |
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
TABLE OF CONTENTS
ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION
On August 5, 2008, Blue Nile, Inc. issued a press release announcing financial results for the
quarter ended June 29, 2008. A copy of the press release is attached hereto as Exhibit 99.1 and is
incorporated herein by reference. The press release should be read in conjunction with the note
regarding forward-looking statements, which is included in the text of the press release.
The information in this Form 8-K and the exhibit attached hereto shall not be deemed filed for
purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed
incorporated by reference in any filing under the Securities Act of 1933, as amended, unless
expressly set forth by specific reference in such filing.
ITEM 5.02. DEPARTURE OF DIRECTORS OR PRINCIPAL OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF
PRINCIPAL OFFICERS
On August 4, 2008, Joe Jimenez notified Blue Nile, Inc. of his decision to resign from its Board of
Directors due to the demands of his position as the Chief Executive Officer of Novartis Pharma AG,
based in Basel, Switzerland. Mr. Jimenezs resignation is effective on August 4, 2008.
In connection with Mr. Jimenezs decision not to stand for re-election, the Board of Directors
reduced the size of the Board of Directors from eight members to seven members effective on August
4, 2008.
ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS
|
|
|
EXHIBIT |
|
|
NUMBER |
|
DESCRIPTION |
|
|
|
99.1
|
|
Press release dated August 5, 2008, issued by Blue Nile, Inc. |